.Attributes Medication, Published online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec got FDA confirmation after an unfavorable trial, which highlights the various complexities and also challenges of medicine growth in this particular setup.